Drybench Patent.

Patent and exclusivity dates in 2030 for NDAs on FDA's Paragraph IV list, as FDA lists them

Each patent and exclusivity date in 2030 that FDA's Orange Book lists, as captured on 14 October 2026, for the 607 NDAs that FDA's Paragraph IV list names, as captured on 17 October 2026, and whose Orange Book capture lists a patent or exclusivity. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured: 14 October 2026
Paragraph IV list captured: 17 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers only NDAs that FDA's Paragraph IV list names and that have Orange Book listings. It does not cover other NDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

FDA's Paragraph IV list names no patent number, so it does not say which of the patents on this page an applicant certified against.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed patent expiry (410)

8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 7,816,383, use patent
patent.txt line 2,062
Flags
use code U-1603
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 7,910,610, use patent
patent.txt line 2,063
Flags
use code U-1604
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 8,013,002, use patent
patent.txt line 2,065
Flags
use code U-1603
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 8,084,475, use patent
patent.txt line 2,066
Flags
use code U-1605
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 8,318,780, use patent
patent.txt line 2,067
Flags
use code U-1606
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 8,648,098, use patent
patent.txt line 2,072
Flags
use code U-1611
Product numbers
001
8 Jan 2030 · NDA 022535 · PIRFENIDONE
US 8,754,109, use patent
patent.txt line 2,074
Flags
use code U-1612
Product numbers
001
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 7,816,383, use patent
patent.txt lines 9,337, 9,380, 9,423
Flags
use code U-2042
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 7,816,383, use patent
patent.txt lines 9,338, 9,381, 9,424
Flags
use code U-2050
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 7,910,610, use patent
patent.txt lines 9,339, 9,382, 9,425
Flags
use code U-2048
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 7,910,610, use patent
patent.txt lines 9,340, 9,383, 9,426
Flags
use code U-2049
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,013,002, use patent
patent.txt lines 9,341, 9,384, 9,427
Flags
use code U-2047
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,013,002, use patent
patent.txt lines 9,342, 9,385, 9,428
Flags
use code U-2082
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,084,475, use patent
patent.txt lines 9,344, 9,386, 9,430
Flags
use code U-2054
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,084,475, use patent
patent.txt lines 9,343, 9,429
Flags
use code U-2052
Product numbers
001, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,084,475, use patent
patent.txt line 9,387
Flags
use code U-2268
Product numbers
002
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,318,780, use patent
patent.txt lines 9,345, 9,388, 9,431
Flags
use code U-2046
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,318,780, use patent
patent.txt lines 9,346, 9,389, 9,432
Flags
use code U-2081
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,648,098, use patent
patent.txt lines 9,365, 9,408, 9,451
Flags
use code U-2051
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,648,098, use patent
patent.txt lines 9,366, 9,409, 9,452
Flags
use code U-2052
Product numbers
001, 002, 003
8 Jan 2030 · NDA 208780 · PIRFENIDONE
US 8,754,109, use patent
patent.txt lines 9,367, 9,410, 9,453
Flags
use code U-2053
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,091,439, substance patent
patent.txt lines 9,179, 9,199, 9,219
Flags
substance
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,091,440, product patent
patent.txt lines 9,180, 9,200, 9,220
Flags
product
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,181, 9,201, 9,221
Flags
use code U-1220
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,182, 9,202, 9,222
Flags
use code U-1480
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,183, 9,203, 9,223
Flags
use code U-2488
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,184, 9,204, 9,224
Flags
use code U-3225
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,185, 9,205, 9,225
Flags
use code U-4131
Product numbers
001, 002, 003
15 Jan 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 11,098,015, use patent
patent.txt lines 9,186, 9,206, 9,226
Flags
use code U-4156
Product numbers
001, 002, 003
17 Jan 2030 · NDA 021527 · IPRATROPIUM BROMIDE
US 8,474,447, product patent
patent.txt line 620
Flags
product delist requested
Product numbers
001
18 Jan 2030 · NDA 202293 · DAPAGLIFLOZIN
US 8,721,615, product patent
patent.txt lines 3,000, 3,038
Flags
product delist requested
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 7,994,185, substance and product and use patent
patent.txt lines 3,253, 3,277
Flags
substance product use code U-1406
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 7,994,185, substance and product and use patent
patent.txt lines 3,254, 3,278
Flags
substance product use code U-2031
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 7,994,185, substance and product and use patent
patent.txt lines 3,255, 3,279
Flags
substance product use code U-2032
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 7,994,185, substance and product and use patent
patent.txt lines 3,256, 3,280
Flags
substance product use code U-2296
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,415,345, substance and product and use patent
patent.txt lines 3,258, 3,282
Flags
substance product use code U-1406
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,415,345, substance and product and use patent
patent.txt lines 3,259, 3,283
Flags
substance product use code U-2031
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,415,345, substance and product and use patent
patent.txt lines 3,260, 3,284
Flags
substance product use code U-2032
Product numbers
001, 002
20 Jan 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,415,345, substance and product and use patent
patent.txt lines 3,261, 3,285
Flags
substance product use code U-2296
Product numbers
001, 002
20 Jan 2030 · NDA 207695 · CRISABOROLE
US 8,168,614, use patent
patent.txt line 7,408
Flags
use code U-1932
Product numbers
001
27 Jan 2030 · NDA 208254 · NETARSUDIL MESYLATE
US 10,174,017, substance and product and use patent
patent.txt line 8,392
Flags
substance product use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208254 · NETARSUDIL MESYLATE
US 10,654,844, substance and product and use patent
patent.txt line 8,395
Flags
substance product use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208254 · NETARSUDIL MESYLATE
US 11,028,081, use patent
patent.txt line 8,399
Flags
use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208254 · NETARSUDIL MESYLATE
US 11,618,748, use patent
patent.txt line 8,401
Flags
use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 10,174,017, substance and product and use patent
patent.txt line 8,407
Flags
substance product use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 10,654,844, substance and product and use patent
patent.txt line 8,410
Flags
substance product use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 11,028,081, use patent
patent.txt line 8,414
Flags
use code U-1524
Product numbers
001
27 Jan 2030 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 11,618,748, use patent
patent.txt line 8,417
Flags
use code U-1524
Product numbers
001
31 Jan 2030 · NDA 022032 · OMEPRAZOLE
US 12,599,565, product patent
patent.txt line 932
Flags
product
Product numbers
001
2 Feb 2030 · NDA 200063 · BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE
US 8,916,195, use patent
patent.txt line 2,210
Flags
use code U-1639
Product numbers
001
4 Feb 2030 · NDA 202331 · AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE
US 9,169,238, product patent
patent.txt lines 3,066, 3,069
Flags
product
Product numbers
001, 002
8 Feb 2030 · NDA 022532 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US 8,617,597, product patent
patent.txt line 2,056
Flags
product
Product numbers
001
8 Feb 2030 · NDA 022574 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US 8,617,597, product patent
patent.txt line 2,108
Flags
product
Product numbers
001
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 12,171,738, use patent
patent.txt lines 2,647, 2,710
Flags
use code U-4105
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,399,446, use patent
patent.txt line 2,712
Flags
use code U-1287
Product numbers
002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,415,335, use patent
patent.txt lines 2,650, 2,714
Flags
use code U-1287
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,426,399, use patent
patent.txt lines 2,651, 2,715
Flags
use code U-1287
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,518,929, use patent
patent.txt lines 2,657, 2,720
Flags
use code U-1287
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,524,698, use patent
patent.txt lines 2,658, 2,721
Flags
use code U-1287
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,546,372, use patent
patent.txt lines 2,659, 2,722
Flags
use code U-1287
Product numbers
001, 002
9 Feb 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,680,144, use patent
patent.txt lines 2,669, 2,731
Flags
use code U-2695
Product numbers
001, 002
10 Feb 2030 · NDA 203923 · SODIUM THIOSULFATE
US 11,753,301, substance and product and use patent
patent.txt line 4,182
Flags
substance product use code U-3682
Product numbers
001
10 Feb 2030 · NDA 203923 · SODIUM THIOSULFATE
US 12,304,813, product patent
patent.txt line 4,183
Flags
product
Product numbers
001
11 Feb 2030 · NDA 204629 · EMPAGLIFLOZIN
US 12,115,179, use patent
patent.txt lines 4,888, 4,919
Flags
use code U-4023
Product numbers
001, 002
11 Feb 2030 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 12,115,179, use patent
patent.txt lines 6,183, 6,215
Flags
use code U-4023
Product numbers
001, 002
11 Feb 2030 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,115,179, use patent
patent.txt lines 6,303, 6,334, 6,363, 6,392
Flags
use code U-4023
Product numbers
001, 002, 003, 004
11 Feb 2030 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,115,179, use patent
patent.txt lines 9,050, 9,082, 9,112, 9,142
Flags
use code U-4023
Product numbers
001, 002, 003, 004
11 Feb 2030 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 12,115,179, use patent
patent.txt lines 14,238, 14,268, 14,298, 14,327
Flags
use code U-4023
Product numbers
001, 002, 003, 004
12 Feb 2030 · NDA 021775 · ALVIMOPAN
US 8,946,262, use patent
patent.txt line 699
Flags
use code U-1655
Product numbers
001
13 Feb 2030 · NDA 203496 · TREPROSTINIL DIOLAMINE
US 8,410,169, product patent
patent.txt lines 3,949, 3,958, 3,967, 3,976, 3,985
Flags
product
Product numbers
001, 002, 003, 004, 005
23 Feb 2030 · NDA 022581 · CALCIUM ACETATE
US 8,591,938, product and use patent
patent.txt line 2,133
Flags
product use code U-1469
Product numbers
001
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt lines 11,504, 11,522
Flags
substance product use code U-2335
Product numbers
001, 002
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt line 11,523
Flags
substance product use code U-2802
Product numbers
002
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt line 11,524
Flags
substance product use code U-2803
Product numbers
002
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt line 11,525
Flags
substance product use code U-3738
Product numbers
002
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt line 11,526
Flags
substance product use code U-4051
Product numbers
002
26 Feb 2030 · NDA 210496 · ENCORAFENIB
US 8,541,575, substance and product and use patent
patent.txt line 11,527
Flags
substance product use code U-4440
Product numbers
002
27 Feb 2030 · NDA 210496 · ENCORAFENIB
US RE49556, substance and product patent
patent.txt line 11,549
Flags
substance product
Product numbers
002
2 Mar 2030 · NDA 206333 · DEOXYCHOLIC ACID
US 10,500,214, product patent
patent.txt line 6,476
Flags
product
Product numbers
001
2 Mar 2030 · NDA 206333 · DEOXYCHOLIC ACID
US 8,101,593, product patent
patent.txt line 6,480
Flags
product
Product numbers
001
2 Mar 2030 · NDA 206333 · DEOXYCHOLIC ACID
US 8,367,649, product patent
patent.txt line 6,482
Flags
product
Product numbers
001
2 Mar 2030 · NDA 206333 · DEOXYCHOLIC ACID
US 8,653,058, product patent
patent.txt line 6,485
Flags
product
Product numbers
001
7 Mar 2030 · NDA 211150 · PITOLISANT HYDROCHLORIDE
US 8,207,197, substance and product patent
patent.txt lines 12,480, 12,485
Flags
substance product
Product numbers
001, 002
8 Mar 2030 · NDA 204275 · FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US 8,534,281, product patent
patent.txt lines 4,434, 4,444, 4,452
Flags
product
Product numbers
001, 002, 003
8 Mar 2030 · NDA 209482 · FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US 8,534,281, product patent
patent.txt lines 10,409, 10,416
Flags
product
Product numbers
001, 002
10 Mar 2030 · NDA 020372 · TECHNETIUM TC-99M TETROFOSMIN KIT
US 9,549,999, product patent
patent.txt line 183
Flags
product
Product numbers
002
11 Mar 2030 · NDA 205858 · IDELALISIB
US 9,492,449, use patent
patent.txt lines 5,991, 5,995
Flags
use code U-1914
Product numbers
001, 002
15 Mar 2030 · NDA 208694 · CETIRIZINE HYDROCHLORIDE
US 8,829,005, use patent
patent.txt line 9,238
Flags
use code U-1680
Product numbers
001
15 Mar 2030 · NDA 208694 · CETIRIZINE HYDROCHLORIDE
US 9,750,684, product patent
patent.txt line 9,241
Flags
product
Product numbers
001
15 Mar 2030 · NDA 208694 · CETIRIZINE HYDROCHLORIDE
US 9,993,471, use patent
patent.txt line 9,242
Flags
use code U-1680
Product numbers
001
17 Mar 2030 · NDA 022287 · DEXLANSOPRAZOLE
US 8,173,158, use patent
patent.txt lines 1,556, 1,570
Flags
use code U-949
Product numbers
001, 002
17 Mar 2030 · NDA 022287 · DEXLANSOPRAZOLE
US 8,173,158, use patent
patent.txt lines 1,557, 1,571
Flags
use code U-950
Product numbers
001, 002
17 Mar 2030 · NDA 022287 · DEXLANSOPRAZOLE
US 8,173,158, use patent
patent.txt lines 1,558, 1,572
Flags
use code U-951
Product numbers
001, 002
24 Mar 2030 · NDA 208051 · NERATINIB MALEATE
US 9,211,291, use patent
patent.txt line 8,028
Flags
use code U-2043
Product numbers
001
24 Mar 2030 · NDA 208051 · NERATINIB MALEATE
US 9,211,291, use patent
patent.txt line 8,029
Flags
use code U-3097
Product numbers
001
26 Mar 2030 · NDA 022410 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 8,475,832, product and use patent
patent.txt lines 1,800, 1,803, 1,806, 1,809
Flags
product use code U-1411
Product numbers
001, 002, 003, 004
29 Mar 2030 · NDA 022272 · OXYCODONE HYDROCHLORIDE
US 8,894,987, product patent
patent.txt lines 1,447, 1,462, 1,477, 1,492
Flags
product
Product numbers
001, 002, 003, 004
5 Apr 2030 · NDA 022192 · ILOPERIDONE
US 9,157,121, use patent
patent.txt lines 1,156, 1,170, 1,184, 1,198, 1,212, 1,226, 1,240
Flags
use code U-1674
Product numbers
001, 002, 003, 004, 005, 006, 007
7 Apr 2030 · NDA 022275 · TOLVAPTAN
US 10,905,694, product patent
patent.txt lines 1,543, 1,545, 1,547
Flags
product
Product numbers
001, 002, 003
7 Apr 2030 · NDA 204441 · TOLVAPTAN
US 10,905,694, product patent
patent.txt lines 4,686, 4,688, 4,690, 4,692, 4,694
Flags
product
Product numbers
001, 002, 003, 004, 005
9 Apr 2030 · NDA 205836 · BRIVARACETAM
US 10,729,653, product patent
patent.txt lines 5,975, 5,977, 5,979, 5,981, 5,983
Flags
product
Product numbers
001, 002, 003, 004, 005
10 Apr 2030 · NDA 201280 · LINAGLIPTIN
US 11,911,388, use patent
patent.txt line 2,330
Flags
use code U-3854
Product numbers
001
10 Apr 2030 · NDA 201281 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 11,911,388, use patent
patent.txt lines 2,348, 2,366, 2,384
Flags
use code U-3854
Product numbers
001, 002, 003
10 Apr 2030 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 11,911,388, use patent
patent.txt lines 7,974, 7,993
Flags
use code U-3854
Product numbers
001, 002
13 Apr 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 10,159,681, use patent
patent.txt line 1,920
Flags
use code U-2510
Product numbers
001
13 Apr 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 10,772,897, use patent
patent.txt line 1,921
Flags
use code U-2958
Product numbers
001
13 Apr 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 9,283,233, use patent
patent.txt line 1,926
Flags
use code U-1821
Product numbers
001
17 Apr 2030 · NDA 022416 · ESLICARBAZEPINE ACETATE
US 8,372,431, product patent
patent.txt lines 1,816, 1,824, 1,832, 1,840
Flags
product
Product numbers
001, 002, 003, 004
17 Apr 2030 · NDA 022433 · TICAGRELOR
US 8,425,934, product patent
patent.txt lines 1,901, 1,906
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 8,679,544, product patent
patent.txt lines 4,842, 4,849
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 8,999,387, use patent
patent.txt lines 4,843, 4,850
Flags
use code U-55
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 9,017,721, product patent
patent.txt lines 4,844, 4,851
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 9,173,854, product patent
patent.txt lines 4,845, 4,852
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 9,180,095, use patent
patent.txt lines 4,846, 4,853
Flags
use code U-55
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 9,180,096, product patent
patent.txt lines 4,847, 4,854
Flags
product
Product numbers
001, 002
23 Apr 2030 · NDA 204592 · DICLOFENAC
US 9,186,328, use patent
patent.txt lines 4,848, 4,855
Flags
use code U-55
Product numbers
001, 002
27 Apr 2030 · NDA 202788 · FENTANYL
US 8,486,972, product patent
patent.txt lines 3,168, 3,178, 3,187, 3,197, 3,207, 3,216, 3,226
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
27 Apr 2030 · NDA 202788 · FENTANYL
US 8,486,973, use patent
patent.txt lines 3,169, 3,179, 3,188, 3,198, 3,208, 3,217, 3,227
Flags
use code U-55
Product numbers
001, 002, 003, 004, 005, 006, 007
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,010,517, use patent
patent.txt lines 2,620, 2,683
Flags
use code U-2690
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,265,287, use patent
patent.txt lines 2,621, 2,684
Flags
use code U-2700
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,792,267, use patent
patent.txt lines 2,633, 2,696
Flags
use code U-2961
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,842,766, use patent
patent.txt lines 2,635, 2,698
Flags
use code U-2997
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,881,632, use patent
patent.txt lines 2,637, 2,700
Flags
use code U-3052
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 11,103,477, use patent
patent.txt lines 2,640, 2,703
Flags
use code U-3209
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 11,154,526, use patent
patent.txt lines 2,642, 2,705
Flags
use code U-3240
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 11,213,504, use patent
patent.txt lines 2,643, 2,706
Flags
use code U-3292
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 11,717,504, use patent
patent.txt lines 2,646, 2,709
Flags
use code U-3669
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,298,554, product patent
patent.txt lines 2,648, 2,711
Flags
product
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,445,003, use patent
patent.txt lines 2,652, 2,716
Flags
use code U-1287
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,445,013, use patent
patent.txt lines 2,653, 2,717
Flags
use code U-1287
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,454,994, use patent
patent.txt lines 2,654, 2,718
Flags
use code U-2689
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,501,225, use patent
patent.txt lines 2,656, 2,719
Flags
use code U-1287
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,563,608, use patent
patent.txt lines 2,660, 2,723
Flags
use code U-1287
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,617,593, use patent
patent.txt line 2,661
Flags
use code U-1478
Product numbers
001
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,617,593, use patent
patent.txt lines 2,662, 2,725
Flags
use code U-2691
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,617,593, use patent
patent.txt line 2,724
Flags
use code U-1287
Product numbers
002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,617,594, use patent
patent.txt lines 2,663, 2,726
Flags
use code U-1287
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,618,166, use patent
patent.txt line 2,664
Flags
use code U-2689
Product numbers
001
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,623,406, use patent
patent.txt line 2,665
Flags
use code U-1478
Product numbers
001
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,623,406, use patent
patent.txt lines 2,666, 2,728
Flags
use code U-2692
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,623,406, use patent
patent.txt line 2,727
Flags
use code U-1287
Product numbers
002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,642,077, use patent
patent.txt lines 2,667, 2,729
Flags
use code U-2693
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,691,871, use patent
patent.txt lines 2,670, 2,732
Flags
use code U-2689
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,703,185, use patent
patent.txt lines 2,671, 2,733
Flags
use code U-2691
Product numbers
001, 002
29 Apr 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,709,475, use patent
patent.txt lines 2,672, 2,734
Flags
use code U-2689
Product numbers
001, 002
29 Apr 2030 · NDA 207318 · PIMAVANSERIN TARTRATE
US 7,601,740, substance and product patent
patent.txt lines 7,233, 7,242
Flags
substance product
Product numbers
001, 002
29 Apr 2030 · NDA 210793 · PIMAVANSERIN TARTRATE
US 7,601,740, substance and product patent
patent.txt line 12,147
Flags
substance product
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 10,918,635, use patent
patent.txt line 1,931
Flags
use code U-1455
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 10,918,635, use patent
patent.txt line 1,932
Flags
use code U-172
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 11,202,752, use patent
patent.txt line 1,933
Flags
use code U-1455
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 11,202,752, use patent
patent.txt line 1,934
Flags
use code U-172
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 11,850,245, use patent
patent.txt line 1,935
Flags
use code U-1455
Product numbers
001
30 Apr 2030 · NDA 022483 · IMIQUIMOD
US 11,850,245, use patent
patent.txt line 1,936
Flags
use code U-172
Product numbers
001
30 Apr 2030 · NDA 203100 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US 8,633,219, product and use patent
patent.txt line 3,638
Flags
product use code U-257
Product numbers
001
30 Apr 2030 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,633,219, product and use patent
patent.txt line 7,355
Flags
product use code U-257
Product numbers
001
1 May 2030 · NDA 022301 · MESALAMINE
US 8,865,688, use patent
patent.txt line 1,605
Flags
use code U-1310
Product numbers
001
16 May 2030 · NDA 209388 · METOCLOPRAMIDE HYDROCHLORIDE
US 8,334,281, product and use patent
patent.txt line 10,293
Flags
product use code U-2843
Product numbers
001
19 May 2030 · NDA 204026 · POMALIDOMIDE
US 10,555,939, product patent
patent.txt lines 4,197, 4,203, 4,209, 4,215
Flags
product
Product numbers
001, 002, 003, 004
19 May 2030 · NDA 204026 · POMALIDOMIDE
US 9,993,467, product patent
patent.txt lines 4,201, 4,207, 4,213, 4,219
Flags
product
Product numbers
001, 002, 003, 004
20 May 2030 · NDA 214938 · VOSORITIDE
US RE48267, use patent
patent.txt lines 16,360, 16,368, 16,376
Flags
use code U-3927
Product numbers
001, 002, 003
21 May 2030 · NDA 201281 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,155,705, product patent
patent.txt lines 2,359, 2,377, 2,395
Flags
product
Product numbers
001, 002, 003
21 May 2030 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,155,705, product patent
patent.txt lines 7,983, 8,002
Flags
product
Product numbers
001, 002
21 May 2030 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,155,705, product patent
patent.txt lines 14,251, 14,281, 14,311, 14,340
Flags
product
Product numbers
001, 002, 003, 004
22 May 2030 · NDA 204242 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US 8,470,361, product and use patent
patent.txt lines 4,375, 4,385, 4,394, 4,403, 4,412, 4,419
Flags
product use code U-1425
Product numbers
001, 002, 003, 004, 005, 006
25 May 2030 · NDA 209092 · RIBOCICLIB SUCCINATE
US 8,685,980, substance and product patent
patent.txt line 9,701
Flags
substance product
Product numbers
001
25 May 2030 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 8,685,980, substance and product patent
patent.txt line 11,046
Flags
substance product
Product numbers
001
26 May 2030 · NDA 202293 · DAPAGLIFLOZIN
US 8,685,934, use patent
patent.txt lines 2,996, 3,034
Flags
use code U-1522
Product numbers
001, 002
26 May 2030 · NDA 205649 · DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 8,685,934, use patent
patent.txt lines 5,717, 5,727, 5,737, 5,747, 5,757
Flags
use code U-1522
Product numbers
001, 002, 003, 004, 005
26 May 2030 · NDA 208573 · VENETOCLAX
US 9,174,982, use patent
patent.txt lines 8,869, 8,883, 8,897
Flags
use code U-2323
Product numbers
001, 002, 003
26 May 2030 · NDA 208573 · VENETOCLAX
US 9,174,982, use patent
patent.txt lines 8,870, 8,884, 8,898
Flags
use code U-2445
Product numbers
001, 002, 003
26 May 2030 · NDA 208573 · VENETOCLAX
US 9,174,982, use patent
patent.txt lines 8,871, 8,885, 8,899
Flags
use code U-2446
Product numbers
001, 002, 003
26 May 2030 · NDA 208573 · VENETOCLAX
US 9,174,982, use patent
patent.txt lines 8,872, 8,886, 8,900
Flags
use code U-2537
Product numbers
001, 002, 003
28 May 2030 · NDA 207155 · MELPHALAN HYDROCHLORIDE
US 10,864,183, product patent
patent.txt line 7,056
Flags
product
Product numbers
001
28 May 2030 · NDA 207155 · MELPHALAN HYDROCHLORIDE
US 11,020,363, product patent
patent.txt line 7,058
Flags
product
Product numbers
001
29 May 2030 · NDA 205739 · PATIROMER SORBITEX CALCIUM
US 8,337,824, substance and use patent
patent.txt lines 5,828, 5,835, 5,842, 5,849
Flags
substance use code U-1766
Product numbers
001, 002, 003, 004
2 Jun 2030 · NDA 022145 · RALTEGRAVIR POTASSIUM
US 8,771,733, substance and product and use patent
patent.txt lines 1,115, 1,120
Flags
substance product use code U-257
Product numbers
001, 002
2 Jun 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 8,512,745, product patent
patent.txt line 1,923
Flags
product
Product numbers
001
2 Jun 2030 · NDA 203085 · REGORAFENIB
US 8,680,124, use patent
patent.txt line 3,606
Flags
use code U-1506
Product numbers
001
3 Jun 2030 · NDA 214120 · AZACITIDINE
US 8,846,628, product and use patent
patent.txt lines 15,552, 15,555
Flags
product use code U-2950
Product numbers
001, 002
4 Jun 2030 · NDA 201280 · LINAGLIPTIN
US 8,846,695, use patent
patent.txt line 2,337
Flags
use code U-1503 delist requested
Product numbers
001
4 Jun 2030 · NDA 201281 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 8,846,695, use patent
patent.txt lines 2,355, 2,373
Flags
use code U-1503
Product numbers
001, 002
4 Jun 2030 · NDA 201281 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 8,846,695, use patent
patent.txt line 2,391
Flags
use code U-1503 delist requested
Product numbers
003
9 Jun 2030 · NDA 208434 · ALECTINIB HYDROCHLORIDE
US 9,440,922, product patent
patent.txt line 8,620
Flags
product
Product numbers
001
12 Jun 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 8,426,392, use patent
patent.txt line 1,922
Flags
use code U-1389
Product numbers
001
12 Jun 2030 · NDA 022474 · ULIPRISTAL ACETATE
US 8,962,603, use patent
patent.txt line 1,925
Flags
use code U-1657
Product numbers
001
14 Jun 2030 · NDA 207155 · MELPHALAN HYDROCHLORIDE
US 10,940,128, product and use patent
patent.txt line 7,057
Flags
product use code U-3086
Product numbers
001
14 Jun 2030 · NDA 210854 · BALOXAVIR MARBOXIL
US 9,815,835, product patent
patent.txt lines 12,192, 12,203, 12,214
Flags
product
Product numbers
001, 002, 003
15 Jun 2030 · NDA 202057 · ICOSAPENT ETHYL
US 10,842,768, use patent
patent.txt lines 2,636, 2,699
Flags
use code U-2688
Product numbers
001, 002
15 Jun 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,410,086, use patent
patent.txt lines 2,649, 2,713
Flags
use code U-2688
Product numbers
001, 002
15 Jun 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,455,472, use patent
patent.txt line 2,655
Flags
use code U-2690
Product numbers
001
15 Jun 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,669,245, use patent
patent.txt lines 2,668, 2,730
Flags
use code U-2694
Product numbers
001, 002
15 Jun 2030 · NDA 202057 · ICOSAPENT ETHYL
US 8,710,041, use patent
patent.txt lines 2,673, 2,735
Flags
use code U-2690
Product numbers
001, 002
15 Jun 2030 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 10,406,172, product and use patent
patent.txt lines 14,228, 14,258, 14,288, 14,318
Flags
product use code U-2733
Product numbers
001, 002, 003, 004
17 Jun 2030 · NDA 204251 · BRIMONIDINE TARTRATE; BRINZOLAMIDE
US 9,421,265, product patent
patent.txt line 4,424
Flags
product
Product numbers
001
17 Jun 2030 · NDA 209531 · NUSINERSEN SODIUM
US 9,717,750, use patent
patent.txt lines 10,620, 10,628, 10,635
Flags
use code U-1942
Product numbers
001, 002, 003
17 Jun 2030 · NDA 209531 · NUSINERSEN SODIUM
US 9,717,750, use patent
patent.txt lines 10,621, 10,629, 10,636
Flags
use code U-1943
Product numbers
001, 002, 003
17 Jun 2030 · NDA 209531 · NUSINERSEN SODIUM
US 9,717,750, use patent
patent.txt lines 10,622, 10,630, 10,637
Flags
use code U-2093
Product numbers
001, 002, 003
17 Jun 2030 · NDA 209531 · NUSINERSEN SODIUM
US 9,717,750, use patent
patent.txt lines 10,623, 10,631, 10,638
Flags
use code U-2094
Product numbers
001, 002, 003
21 Jun 2030 · NDA 211192 · IVOSIDENIB
US 10,610,125, use patent
patent.txt line 12,511
Flags
use code U-2784
Product numbers
001
21 Jun 2030 · NDA 211192 · IVOSIDENIB
US 10,610,125, use patent
patent.txt line 12,512
Flags
use code U-2785
Product numbers
001
21 Jun 2030 · NDA 211192 · IVOSIDENIB
US 10,610,125, use patent
patent.txt line 12,513
Flags
use code U-3385
Product numbers
001
25 Jun 2030 · NDA 207947 · SELEXIPAG
US 9,284,280, use patent
patent.txt lines 7,705, 7,717, 7,729, 7,741, 7,753, 7,765, 7,777, 7,789, 7,801, 7,813
Flags
use code U-1831
Product numbers
001, 002, 003, 004, 005, 006, 007, 008, 010, 011
25 Jun 2030 · NDA 214275 · SELEXIPAG
US 9,284,280, use patent
patent.txt line 15,665
Flags
use code U-1831
Product numbers
001
4 Jul 2030 · NDA 203752 · ESTRADIOL
US 8,231,906, substance and product patent
patent.txt lines 4,125, 4,128, 4,131, 4,134, 4,137
Flags
substance product
Product numbers
001, 002, 003, 004, 005
5 Jul 2030 · NDA 201292 · AFATINIB DIMALEATE
US 10,004,743, product patent
patent.txt lines 2,399, 2,409, 2,419
Flags
product
Product numbers
001, 002, 003
6 Jul 2030 · NDA 204353 · CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 11,576,894, product patent
patent.txt lines 4,506, 4,517, 4,528, 4,539
Flags
product
Product numbers
001, 002, 003, 004
7 Jul 2030 · NDA 203923 · SODIUM THIOSULFATE
US 10,479,686, product and use patent
patent.txt line 4,181
Flags
product use code U-3390
Product numbers
001
7 Jul 2030 · NDA 203923 · SODIUM THIOSULFATE
US 9,345,724, substance and product and use patent
patent.txt line 4,185
Flags
substance product use code U-2015
Product numbers
001
7 Jul 2030 · NDA 203923 · SODIUM THIOSULFATE
US 9,585,912, substance and product patent
patent.txt line 4,186
Flags
substance product
Product numbers
001
7 Jul 2030 · NDA 211280 · LASMIDITAN SUCCINATE
US 12,257,246, use patent
patent.txt lines 12,665, 12,669, 12,672
Flags
use code U-2718
Product numbers
001, 002, 003
8 Jul 2030 · NDA 203567 · EFINACONAZOLE
US 10,105,444, product patent
patent.txt line 4,087
Flags
product
Product numbers
001
8 Jul 2030 · NDA 203567 · EFINACONAZOLE
US 8,039,494, use patent
patent.txt line 4,098
Flags
use code U-281
Product numbers
001
8 Jul 2030 · NDA 203567 · EFINACONAZOLE
US 9,861,698, product patent
patent.txt line 4,103
Flags
product
Product numbers
001
14 Jul 2030 · NDA 208144 · BRIMONIDINE TARTRATE
US 8,293,742, use patent
patent.txt line 8,271
Flags
use code U-2222
Product numbers
001
14 Jul 2030 · NDA 208144 · BRIMONIDINE TARTRATE
US 9,259,425, use patent
patent.txt line 8,272
Flags
use code U-2222
Product numbers
001
14 Jul 2030 · NDA 210598 · REVEFENACIN
US 10,550,081, substance patent
patent.txt line 12,037
Flags
substance
Product numbers
001
14 Jul 2030 · NDA 210598 · REVEFENACIN
US 11,008,289, use patent
patent.txt line 12,038
Flags
use code U-2440
Product numbers
001
14 Jul 2030 · NDA 210598 · REVEFENACIN
US 11,691,948, product patent
patent.txt line 12,040
Flags
product
Product numbers
001
14 Jul 2030 · NDA 210598 · REVEFENACIN
US 11,858,898, substance and product and use patent
patent.txt line 12,041
Flags
substance product use code U-2440
Product numbers
001
14 Jul 2030 · NDA 210598 · REVEFENACIN
US 9,765,028, substance patent
patent.txt line 12,046
Flags
substance
Product numbers
001
14 Jul 2030 · NDA 218424 · BRIMONIDINE TARTRATE
US 8,293,742, use patent
patent.txt line 21,083
Flags
use code U-2222
Product numbers
001
14 Jul 2030 · NDA 218424 · BRIMONIDINE TARTRATE
US 9,259,425, use patent
patent.txt line 21,084
Flags
use code U-2222
Product numbers
001
17 Jul 2030 · NDA 022532 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US 11,617,751, product and use patent
patent.txt line 2,052
Flags
product use code U-1
Product numbers
001
17 Jul 2030 · NDA 022532 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US 11,617,751, product and use patent
patent.txt line 2,053
Flags
product use code U-3572
Product numbers
001
17 Jul 2030 · NDA 022532 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US 11,617,751, product and use patent
patent.txt line 2,054
Flags
product use code U-3573
Product numbers
001
17 Jul 2030 · NDA 022532 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US 11,617,751, product and use patent
patent.txt line 2,055
Flags
product use code U-3574
Product numbers
001
17 Jul 2030 · NDA 022574 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US 11,617,751, product and use patent
patent.txt line 2,106
Flags
product use code U-1
Product numbers
001
17 Jul 2030 · NDA 022574 · DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM
US 11,617,751, product and use patent
patent.txt line 2,107
Flags
product use code U-3572
Product numbers
001
18 Jul 2030 · NDA 210361 · GLYCOPYRRONIUM TOSYLATE
US 9,744,105, product and use patent
patent.txt line 11,318
Flags
product use code U-2398
Product numbers
001
21 Jul 2030 · NDA 205874 · FERRIC CITRATE
US 10,300,039, use patent
patent.txt line 5,996
Flags
use code U-2549
Product numbers
001
21 Jul 2030 · NDA 205874 · FERRIC CITRATE
US 9,387,191, product patent
patent.txt line 5,998
Flags
product
Product numbers
001
24 Jul 2030 · NDA 022192 · ILOPERIDONE
US 10,563,259, use patent
patent.txt lines 1,143, 1,157, 1,171, 1,185, 1,199, 1,213, 1,227
Flags
use code U-4562
Product numbers
001, 002, 003, 004, 005, 006, 007
24 Jul 2030 · NDA 022192 · ILOPERIDONE
US 10,563,259, use patent
patent.txt lines 1,144, 1,158, 1,172, 1,186, 1,200, 1,214, 1,228
Flags
use code U-4563
Product numbers
001, 002, 003, 004, 005, 006, 007
25 Jul 2030 · NDA 213433 · CLASCOTERONE
US 8,785,427, product patent
patent.txt line 15,010
Flags
product
Product numbers
001
28 Jul 2030 · NDA 021529 · ETONOGESTREL
US 9,757,552, product and use patent
patent.txt lines 623, 627
Flags
product use code U-1
Product numbers
001, 002
28 Jul 2030 · NDA 211349 · GILTERITINIB FUMARATE
US 9,487,491, use patent
patent.txt line 12,714
Flags
use code U-2456
Product numbers
001
29 Jul 2030 · NDA 208325 · ETELCALCETIDE
US 8,377,880, substance and product patent
patent.txt lines 8,462, 8,470, 8,478
Flags
substance product
Product numbers
001, 002, 003
29 Jul 2030 · NDA 208325 · ETELCALCETIDE
US 9,278,995, substance patent
patent.txt lines 8,464, 8,472, 8,480
Flags
substance
Product numbers
001, 002, 003
29 Jul 2030 · NDA 208325 · ETELCALCETIDE
US 9,701,712, substance and product and use patent
patent.txt lines 8,465, 8,473, 8,481
Flags
substance product use code U-2014
Product numbers
001, 002, 003
1 Aug 2030 · NDA 207947 · SELEXIPAG
US 8,791,122, substance and product patent
patent.txt lines 7,701, 7,713, 7,725, 7,737, 7,749, 7,761, 7,773, 7,785, 7,797, 7,809
Flags
substance product
Product numbers
001, 002, 003, 004, 005, 006, 007, 008, 010, 011
1 Aug 2030 · NDA 214275 · SELEXIPAG
US 8,791,122, substance and product patent
patent.txt line 15,661
Flags
substance product
Product numbers
001
2 Aug 2030 · NDA 201373 · FEXOFENADINE HYDROCHLORIDE
US 8,933,097, product patent
patent.txt lines 2,428–2,429
Flags
product
Product numbers
001, 002
9 Aug 2030 · NDA 020947 · DICLOFENAC SODIUM
US 8,546,450, use patent
patent.txt line 384
Flags
use code U-1435
Product numbers
001
9 Aug 2030 · NDA 020947 · DICLOFENAC SODIUM
US 8,546,450, use patent
patent.txt line 385
Flags
use code U-1436
Product numbers
001
9 Aug 2030 · NDA 204623 · DICLOFENAC SODIUM
US 8,546,450, use patent
patent.txt line 4,858
Flags
use code U-1435
Product numbers
001
9 Aug 2030 · NDA 204623 · DICLOFENAC SODIUM
US 8,546,450, use patent
patent.txt line 4,859
Flags
use code U-1436
Product numbers
001
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 10,005,761, use patent
patent.txt lines 11,503, 11,513
Flags
use code U-2335
Product numbers
001, 002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 10,005,761, use patent
patent.txt line 11,514
Flags
use code U-2802
Product numbers
002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 10,005,761, use patent
patent.txt line 11,515
Flags
use code U-2803
Product numbers
002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 10,005,761, use patent
patent.txt line 11,516
Flags
use code U-3738
Product numbers
002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 10,005,761, use patent
patent.txt line 11,517
Flags
use code U-4051
Product numbers
002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 10,005,761, use patent
patent.txt line 11,518
Flags
use code U-4440
Product numbers
002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 9,593,099, substance patent
patent.txt lines 11,508, 11,539
Flags
substance
Product numbers
001, 002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 9,593,100, product patent
patent.txt lines 11,509, 11,540
Flags
product
Product numbers
001, 002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 9,850,229, use patent
patent.txt lines 11,511, 11,542
Flags
use code U-2337
Product numbers
001, 002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 9,850,230, use patent
patent.txt lines 11,512, 11,543
Flags
use code U-2334
Product numbers
001, 002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 9,850,230, use patent
patent.txt line 11,544
Flags
use code U-2802
Product numbers
002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 9,850,230, use patent
patent.txt line 11,545
Flags
use code U-2803
Product numbers
002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 9,850,230, use patent
patent.txt line 11,546
Flags
use code U-3738
Product numbers
002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 9,850,230, use patent
patent.txt line 11,547
Flags
use code U-4051
Product numbers
002
27 Aug 2030 · NDA 210496 · ENCORAFENIB
US 9,850,230, use patent
patent.txt line 11,548
Flags
use code U-4440
Product numbers
002
27 Aug 2030 · NDA 210498 · BINIMETINIB
US 10,005,761, use patent
patent.txt line 11,550
Flags
use code U-2331
Product numbers
001
27 Aug 2030 · NDA 210498 · BINIMETINIB
US 10,005,761, use patent
patent.txt line 11,551
Flags
use code U-3737
Product numbers
001
27 Aug 2030 · NDA 210498 · BINIMETINIB
US 9,850,229, use patent
patent.txt line 11,557
Flags
use code U-2333
Product numbers
001
31 Aug 2030 · NDA 022192 · ILOPERIDONE
US 8,652,776, use patent
patent.txt lines 1,150, 1,164, 1,178, 1,192, 1,206, 1,220, 1,234
Flags
use code U-1685
Product numbers
001, 002, 003, 004, 005, 006, 007
31 Aug 2030 · NDA 208079 · BETAMETHASONE DIPROPIONATE
US 10,179,137, product and use patent
patent.txt line 8,100
Flags
product use code U-1858
Product numbers
001
31 Aug 2030 · NDA 208079 · BETAMETHASONE DIPROPIONATE
US 9,364,485, product and use patent
patent.txt line 8,102
Flags
product use code U-1858
Product numbers
001
31 Aug 2030 · NDA 208079 · BETAMETHASONE DIPROPIONATE
US 9,433,630, product and use patent
patent.txt line 8,103
Flags
product use code U-1858
Product numbers
001
31 Aug 2030 · NDA 208079 · BETAMETHASONE DIPROPIONATE
US 9,439,911, product and use patent
patent.txt line 8,104
Flags
product use code U-1858
Product numbers
001
31 Aug 2030 · NDA 208079 · BETAMETHASONE DIPROPIONATE
US 9,655,907, product and use patent
patent.txt line 8,105
Flags
product use code U-1858
Product numbers
001
31 Aug 2030 · NDA 208079 · BETAMETHASONE DIPROPIONATE
US 9,775,851, product and use patent
patent.txt line 8,106
Flags
product use code U-1858
Product numbers
001
31 Aug 2030 · NDA 208079 · BETAMETHASONE DIPROPIONATE
US 9,877,974, product and use patent
patent.txt line 8,107
Flags
product use code U-1858
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 10,064,875, product and use patent
patent.txt line 10,420
Flags
product use code U-1408
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 10,064,875, product and use patent
patent.txt line 10,421
Flags
product use code U-1858
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 10,064,875, product and use patent
patent.txt line 10,422
Flags
product use code U-193
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 10,064,875, product and use patent
patent.txt line 10,423
Flags
product use code U-742
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 10,064,875, product and use patent
patent.txt line 10,424
Flags
product use code U-88
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 10,588,914, product and use patent
patent.txt line 10,425
Flags
product use code U-2771
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 11,179,465, product and use patent
patent.txt line 10,426
Flags
product use code U-1858
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 9,956,231, product and use patent
patent.txt line 10,428
Flags
product use code U-1408
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 9,956,231, product and use patent
patent.txt line 10,429
Flags
product use code U-1761
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 9,956,231, product and use patent
patent.txt line 10,430
Flags
product use code U-1858
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 9,956,231, product and use patent
patent.txt line 10,431
Flags
product use code U-193
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 9,956,231, product and use patent
patent.txt line 10,432
Flags
product use code U-742
Product numbers
001
31 Aug 2030 · NDA 209483 · CLOBETASOL PROPIONATE
US 9,956,231, product and use patent
patent.txt line 10,433
Flags
product use code U-88
Product numbers
001
31 Aug 2030 · NDA 211210 · MELOXICAM
US 8,545,879, product patent
patent.txt lines 12,541–12,542
Flags
product
Product numbers
001, 002
7 Sep 2030 · NDA 022036 · DOXEPIN HYDROCHLORIDE
US 8,513,299, use patent
patent.txt lines 942, 958
Flags
use code U-620
Product numbers
001, 002
13 Sep 2030 · NDA 204671 · SOFOSBUVIR
US 9,284,342, substance and product and use patent
patent.txt lines 4,960, 4,978
Flags
substance product use code U-1470
Product numbers
001, 002
14 Sep 2030 · NDA 202992 · TERIFLUNOMIDE
US 8,802,735, product patent
patent.txt lines 3,591, 3,597
Flags
product
Product numbers
001, 002
21 Sep 2030 · NDA 200327 · CEFTAROLINE FOSAMIL
US 9,629,861, product patent
patent.txt lines 2,217, 2,219
Flags
product
Product numbers
001, 002
22 Sep 2030 · NDA 022192 · ILOPERIDONE
US 12,606,869, use patent
patent.txt lines 1,147, 1,161, 1,175, 1,189, 1,203, 1,217, 1,231
Flags
use code U-4504
Product numbers
001, 002, 003, 004, 005, 006, 007
22 Sep 2030 · NDA 022192 · ILOPERIDONE
US 12,606,869, use patent
patent.txt lines 1,148, 1,162, 1,176, 1,190, 1,204, 1,218, 1,232
Flags
use code U-4505
Product numbers
001, 002, 003, 004, 005, 006, 007
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 10,045,958, use patent
patent.txt line 3,690
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 10,045,959, use patent
patent.txt line 3,691
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 10,183,002, use patent
patent.txt line 3,692
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 10,183,003, use patent
patent.txt line 3,693
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 10,183,004, use patent
patent.txt line 3,694
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 10,183,005, use patent
patent.txt line 3,695
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 10,183,006, use patent
patent.txt line 3,696
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 10,668,040, use patent
patent.txt line 3,697
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 8,642,012, use patent
patent.txt line 3,698
Flags
use code U-1383
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 9,254,278, use patent
patent.txt line 3,699
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 9,326,966, use patent
patent.txt line 3,700
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 9,561,197, use patent
patent.txt line 3,701
Flags
use code U-1383
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 9,962,359, use patent
patent.txt line 3,702
Flags
use code U-1816
Product numbers
001
22 Sep 2030 · NDA 203284 · GLYCEROL PHENYLBUTYRATE
US 9,999,608, use patent
patent.txt line 3,703
Flags
use code U-1816
Product numbers
001
30 Sep 2030 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 10,610,489, product patent
patent.txt lines 6,293, 6,324, 6,355, 6,384
Flags
product
Product numbers
001, 002, 003, 004
1 Oct 2030 · NDA 212379 · MINOCYCLINE HYDROCHLORIDE
US 10,086,080, use patent
patent.txt line 13,954
Flags
use code U-2647
Product numbers
001
1 Oct 2030 · NDA 212379 · MINOCYCLINE HYDROCHLORIDE
US 10,137,200, use patent
patent.txt line 13,955
Flags
use code U-2647
Product numbers
001
1 Oct 2030 · NDA 212379 · MINOCYCLINE HYDROCHLORIDE
US 10,213,512, product and use patent
patent.txt line 13,956
Flags
product use code U-2647
Product numbers
001
1 Oct 2030 · NDA 212379 · MINOCYCLINE HYDROCHLORIDE
US 10,265,404, product patent
patent.txt line 13,957
Flags
product
Product numbers
001
1 Oct 2030 · NDA 212379 · MINOCYCLINE HYDROCHLORIDE
US 10,517,882, use patent
patent.txt line 13,959
Flags
use code U-2647
Product numbers
001
1 Oct 2030 · NDA 212379 · MINOCYCLINE HYDROCHLORIDE
US 10,821,187, use patent
patent.txt line 13,960
Flags
use code U-2647
Product numbers
001
1 Oct 2030 · NDA 212379 · MINOCYCLINE HYDROCHLORIDE
US 8,865,139, product and use patent
patent.txt line 13,962
Flags
product use code U-2647
Product numbers
001
1 Oct 2030 · NDA 212379 · MINOCYCLINE HYDROCHLORIDE
US 8,945,516, product patent
patent.txt line 13,963
Flags
product
Product numbers
001
1 Oct 2030 · NDA 212379 · MINOCYCLINE HYDROCHLORIDE
US 8,992,896, product and use patent
patent.txt line 13,964
Flags
product use code U-2647
Product numbers
001
1 Oct 2030 · NDA 212379 · MINOCYCLINE HYDROCHLORIDE
US 9,675,700, product and use patent
patent.txt line 13,965
Flags
product use code U-2647
Product numbers
001
1 Oct 2030 · NDA 213690 · MINOCYCLINE HYDROCHLORIDE
US 10,213,512, product and use patent
patent.txt line 15,197
Flags
product use code U-1631
Product numbers
001
1 Oct 2030 · NDA 213690 · MINOCYCLINE HYDROCHLORIDE
US 10,265,404, product patent
patent.txt line 15,198
Flags
product
Product numbers
001
1 Oct 2030 · NDA 213690 · MINOCYCLINE HYDROCHLORIDE
US 10,322,186, use patent
patent.txt line 15,199
Flags
use code U-1631
Product numbers
001
1 Oct 2030 · NDA 213690 · MINOCYCLINE HYDROCHLORIDE
US 10,946,101, use patent
patent.txt line 15,200
Flags
use code U-1631
Product numbers
001
1 Oct 2030 · NDA 213690 · MINOCYCLINE HYDROCHLORIDE
US 12,138,311, use patent
patent.txt line 15,201
Flags
use code U-1631
Product numbers
001
1 Oct 2030 · NDA 213690 · MINOCYCLINE HYDROCHLORIDE
US 12,661,407, use patent
patent.txt line 15,202
Flags
use code U-1631
Product numbers
001
1 Oct 2030 · NDA 213690 · MINOCYCLINE HYDROCHLORIDE
US 8,865,139, product and use patent
patent.txt line 15,203
Flags
product use code U-1631
Product numbers
001
1 Oct 2030 · NDA 213690 · MINOCYCLINE HYDROCHLORIDE
US 8,945,516, product patent
patent.txt line 15,204
Flags
product
Product numbers
001
1 Oct 2030 · NDA 213690 · MINOCYCLINE HYDROCHLORIDE
US 8,992,896, product and use patent
patent.txt line 15,205
Flags
product use code U-1631
Product numbers
001
1 Oct 2030 · NDA 213690 · MINOCYCLINE HYDROCHLORIDE
US 9,675,700, product and use patent
patent.txt line 15,206
Flags
product use code U-1631
Product numbers
001
4 Oct 2030 · NDA 206947 · LENVATINIB MESYLATE
US 12,508,313, product patent
patent.txt lines 6,888, 6,909
Flags
product
Product numbers
001, 002
8 Oct 2030 · NDA 206494 · AVIBACTAM SODIUM; CEFTAZIDIME
US 8,835,455, product patent
patent.txt line 6,579
Flags
product
Product numbers
001
8 Oct 2030 · NDA 208692 · CABOZANTINIB S-MALATE
US 8,877,776, substance and product and use patent
patent.txt lines 9,195, 9,215, 9,235
Flags
substance product use code U-3225
Product numbers
001, 002, 003
11 Oct 2030 · NDA 204275 · FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US 8,746,242, product patent
patent.txt lines 4,436, 4,446, 4,454
Flags
product
Product numbers
001, 002, 003
11 Oct 2030 · NDA 209482 · FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US 8,746,242, product patent
patent.txt lines 10,411, 10,418
Flags
product
Product numbers
001, 002
15 Oct 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,703,781, substance and product and use patent
patent.txt lines 3,263, 3,287
Flags
substance product use code U-1713
Product numbers
001, 002
15 Oct 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,703,781, substance and product and use patent
patent.txt lines 3,264, 3,288
Flags
substance product use code U-2032
Product numbers
001, 002
15 Oct 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,703,781, substance and product and use patent
patent.txt lines 3,265, 3,289
Flags
substance product use code U-2296
Product numbers
001, 002
15 Oct 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,703,781, substance and product and use patent
patent.txt lines 3,266, 3,290
Flags
substance product use code U-2298
Product numbers
001, 002
15 Oct 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,952,018, use patent
patent.txt lines 3,268, 3,292
Flags
use code U-2027
Product numbers
001, 002
15 Oct 2030 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 8,703,781, substance and product and use patent
patent.txt lines 4,278, 4,298, 4,318
Flags
substance product use code U-1712
Product numbers
001, 002, 003
15 Oct 2030 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 8,703,781, substance and product and use patent
patent.txt lines 4,279, 4,299, 4,319
Flags
substance product use code U-2020
Product numbers
001, 002, 003
15 Oct 2030 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 8,703,781, substance and product and use patent
patent.txt lines 4,280, 4,300, 4,320
Flags
substance product use code U-2037
Product numbers
001, 002, 003
15 Oct 2030 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 8,703,781, substance and product and use patent
patent.txt lines 4,281, 4,301, 4,321
Flags
substance product use code U-2302
Product numbers
001, 002, 003
15 Oct 2030 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 8,703,781, substance and product and use patent
patent.txt lines 4,282, 4,302, 4,322
Flags
substance product use code U-2305
Product numbers
001, 002, 003
15 Oct 2030 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
US 8,952,018, use patent
patent.txt lines 4,284, 4,304, 4,324
Flags
use code U-2020
Product numbers
001, 002, 003
16 Oct 2030 · NDA 021747 · ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
US 8,733,341, product patent
patent.txt line 697
Flags
product delist requested
Product numbers
001
16 Oct 2030 · NDA 021936 · TIOTROPIUM BROMIDE
US 8,733,341, product patent
patent.txt line 813
Flags
product delist requested
Product numbers
001
16 Oct 2030 · NDA 206756 · OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE
US 8,733,341, product patent
patent.txt line 6,761
Flags
product delist requested
Product numbers
001
21 Oct 2030 · NDA 022145 · RALTEGRAVIR POTASSIUM
US 9,649,311, product patent
patent.txt line 1,122
Flags
product
Product numbers
002
21 Oct 2030 · NDA 208073 · LIFITEGRAST
US 9,353,088, product patent
patent.txt line 8,091
Flags
product
Product numbers
001
21 Oct 2030 · NDA 208073 · LIFITEGRAST
US 9,890,141, substance patent
patent.txt line 8,093
Flags
substance
Product numbers
001
24 Oct 2030 · NDA 203567 · EFINACONAZOLE
US 8,486,978, product patent
patent.txt line 4,099
Flags
product
Product numbers
001
24 Oct 2030 · NDA 203567 · EFINACONAZOLE
US 9,302,009, product patent
patent.txt line 4,100
Flags
product
Product numbers
001
26 Oct 2030 · NDA 022249 · BENDAMUSTINE HYDROCHLORIDE
US 8,436,190, product patent
patent.txt lines 1,362, 1,379
Flags
product
Product numbers
001, 002
27 Oct 2030 · NDA 201023 · CABAZITAXEL
US 10,583,110, use patent
patent.txt line 2,313
Flags
use code U-2753
Product numbers
001
27 Oct 2030 · NDA 201023 · CABAZITAXEL
US 10,716,777, use patent
patent.txt line 2,315
Flags
use code U-2856
Product numbers
001
27 Oct 2030 · NDA 201023 · CABAZITAXEL
US 12,453,712, use patent
patent.txt line 2,317
Flags
use code U-4334
Product numbers
001
27 Oct 2030 · NDA 201023 · CABAZITAXEL
US 8,927,592, use patent
patent.txt line 2,321
Flags
use code U-3200
Product numbers
001
27 Oct 2030 · NDA 212099 · DAROLUTAMIDE
US 10,711,013, substance and product patent
patent.txt line 13,534
Flags
substance product
Product numbers
001
27 Oct 2030 · NDA 212099 · DAROLUTAMIDE
US 11,046,713, substance patent
patent.txt line 13,539
Flags
substance
Product numbers
001
27 Oct 2030 · NDA 212099 · DAROLUTAMIDE
US 9,657,003, substance and product and use patent
patent.txt line 13,546
Flags
substance product use code U-4208
Product numbers
001
27 Oct 2030 · NDA 212099 · DAROLUTAMIDE
US 9,657,003, substance and product and use patent
patent.txt line 13,547
Flags
substance product use code U-4209
Product numbers
001
27 Oct 2030 · NDA 212099 · DAROLUTAMIDE
US 9,657,003, substance and product and use patent
patent.txt line 13,548
Flags
substance product use code U-4210
Product numbers
001
28 Oct 2030 · NDA 022192 · ILOPERIDONE
US 8,999,638, use patent
patent.txt lines 1,151, 1,165, 1,179, 1,193, 1,207, 1,221, 1,235
Flags
use code U-1674
Product numbers
001, 002, 003, 004, 005, 006, 007
30 Oct 2030 · NDA 204251 · BRIMONIDINE TARTRATE; BRINZOLAMIDE
US 9,044,484, product patent
patent.txt line 4,423
Flags
product
Product numbers
001
5 Nov 2030 · NDA 208051 · NERATINIB MALEATE
US 8,790,708, product and use patent
patent.txt line 8,022
Flags
product use code U-2043
Product numbers
001
5 Nov 2030 · NDA 208051 · NERATINIB MALEATE
US 8,790,708, product and use patent
patent.txt line 8,023
Flags
product use code U-3047
Product numbers
001
5 Nov 2030 · NDA 208051 · NERATINIB MALEATE
US 8,790,708, product and use patent
patent.txt line 8,024
Flags
product use code U-3097
Product numbers
001
10 Nov 2030 · NDA 204958 · CANGRELOR
US 9,427,448, use patent
patent.txt line 5,185
Flags
use code U-1926
Product numbers
001
10 Nov 2030 · NDA 208254 · NETARSUDIL MESYLATE
US 8,394,826, substance and product and use patent
patent.txt line 8,402
Flags
substance product use code U-1524
Product numbers
001
10 Nov 2030 · NDA 208259 · LATANOPROST; NETARSUDIL DIMESYLATE
US 8,394,826, substance and product and use patent
patent.txt line 8,418
Flags
substance product use code U-1524
Product numbers
001
12 Nov 2030 · NDA 205649 · DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 9,616,028, product patent
patent.txt lines 5,719, 5,729, 5,739, 5,749, 5,759
Flags
product
Product numbers
001, 002, 003, 004, 005
12 Nov 2030 · NDA 208073 · LIFITEGRAST
US 8,927,574, product patent
patent.txt line 8,089
Flags
product
Product numbers
001
18 Nov 2030 · NDA 210493 · FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE
US 9,186,357, use patent
patent.txt lines 11,488, 11,500
Flags
use code U-2301
Product numbers
001, 002
20 Nov 2030 · NDA 208051 · NERATINIB MALEATE
US 8,518,446, product and use patent
patent.txt line 8,018
Flags
product use code U-2043
Product numbers
001
20 Nov 2030 · NDA 208051 · NERATINIB MALEATE
US 8,518,446, product and use patent
patent.txt line 8,019
Flags
product use code U-3047
Product numbers
001
20 Nov 2030 · NDA 208051 · NERATINIB MALEATE
US 8,518,446, product and use patent
patent.txt line 8,020
Flags
product use code U-3097
Product numbers
001
20 Nov 2030 · NDA 209360 · ANGIOTENSIN II ACETATE
US 9,572,856, use patent
patent.txt line 10,205
Flags
use code U-2221
Product numbers
002
23 Nov 2030 · NDA 021572 · DAPTOMYCIN
US 9,138,456, product patent
patent.txt line 638
Flags
product
Product numbers
003
24 Nov 2030 · NDA 205494 · ELIGLUSTAT TARTRATE
US 11,458,119, substance and product patent
patent.txt line 5,455
Flags
substance product
Product numbers
001
24 Nov 2030 · NDA 209299 · FOSTAMATINIB DISODIUM
US 8,263,122, product patent
patent.txt lines 10,043, 10,057
Flags
product
Product numbers
001, 002
24 Nov 2030 · NDA 209531 · NUSINERSEN SODIUM
US 8,980,853, use patent
patent.txt lines 10,619, 10,627, 10,634
Flags
use code U-1941
Product numbers
001, 002, 003
29 Nov 2030 · NDA 209482 · FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US 11,090,294, use patent
patent.txt line 10,405
Flags
use code U-3202
Product numbers
001
29 Nov 2030 · NDA 209482 · FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US 12,396,986, product patent
patent.txt lines 10,406, 10,413
Flags
product
Product numbers
001, 002
29 Nov 2030 · NDA 209482 · FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US 9,750,726, product patent
patent.txt lines 10,412, 10,419
Flags
product
Product numbers
001, 002
30 Nov 2030 · NDA 209884 · SIPONIMOD
US 8,492,441, use patent
patent.txt lines 10,989, 10,994, 10,999
Flags
use code U-2511
Product numbers
001, 002, 003
1 Dec 2030 · NDA 203491 · NEPAFENAC
US 9,662,398, product patent
patent.txt line 3,945
Flags
product
Product numbers
001
1 Dec 2030 · NDA 204734 · LANTHANUM CARBONATE
US 8,980,327, product patent
patent.txt lines 4,988, 4,990
Flags
product
Product numbers
001, 002
1 Dec 2030 · NDA 204734 · LANTHANUM CARBONATE
US 9,023,397, product patent
patent.txt lines 4,989, 4,991
Flags
product
Product numbers
001, 002
2 Dec 2030 · NDA 207997 · MIDOSTAURIN
US 8,575,146, use patent
patent.txt line 7,933
Flags
use code U-2008
Product numbers
001
2 Dec 2030 · NDA 208944 · AMANTADINE HYDROCHLORIDE
US 11,197,835, use patent
patent.txt lines 9,620, 9,637
Flags
use code U-2106
Product numbers
001, 002
2 Dec 2030 · NDA 208944 · AMANTADINE HYDROCHLORIDE
US 8,741,343, use patent
patent.txt lines 9,626, 9,643
Flags
use code U-2106
Product numbers
001, 002
2 Dec 2030 · NDA 208944 · AMANTADINE HYDROCHLORIDE
US 9,867,791, use patent
patent.txt lines 9,627, 9,644
Flags
use code U-2106
Product numbers
001, 002
2 Dec 2030 · NDA 208944 · AMANTADINE HYDROCHLORIDE
US 9,867,792, use patent
patent.txt lines 9,628, 9,645
Flags
use code U-2106
Product numbers
001, 002
2 Dec 2030 · NDA 208944 · AMANTADINE HYDROCHLORIDE
US 9,867,793, use patent
patent.txt lines 9,629, 9,646
Flags
use code U-2106
Product numbers
001, 002
2 Dec 2030 · NDA 208944 · AMANTADINE HYDROCHLORIDE
US 9,877,933, use patent
patent.txt lines 9,630, 9,647
Flags
use code U-2224
Product numbers
001, 002
3 Dec 2030 · NDA 211616 · BEMPEDOIC ACID
US 7,335,799, substance patent
patent.txt line 12,897
Flags
substance
Product numbers
001
3 Dec 2030 · NDA 211617 · BEMPEDOIC ACID; EZETIMIBE
US 7,335,799, substance patent
patent.txt line 12,907
Flags
substance
Product numbers
001
6 Dec 2030 · NDA 022318 · SEVELAMER CARBONATE
US 9,095,509, product patent
patent.txt lines 1,644–1,645
Flags
product
Product numbers
001, 002
10 Dec 2030 · NDA 208090 · OXYCODONE
US 10,004,729, product and use patent
patent.txt lines 8,223, 8,231, 8,239, 8,247, 8,255
Flags
product use code U-1556
Product numbers
001, 002, 003, 004, 005
10 Dec 2030 · NDA 208090 · OXYCODONE
US 10,668,060, product and use patent
patent.txt lines 8,226, 8,234, 8,242, 8,250, 8,258
Flags
product use code U-1556
Product numbers
001, 002, 003, 004, 005
10 Dec 2030 · NDA 208090 · OXYCODONE
US 9,682,075, product and use patent
patent.txt lines 8,228, 8,236, 8,244, 8,252, 8,260
Flags
product use code U-1556
Product numbers
001, 002, 003, 004, 005
11 Dec 2030 · NDA 204671 · SOFOSBUVIR
US 8,618,076, substance and product and use patent
patent.txt lines 4,952, 4,970
Flags
substance product use code U-1470
Product numbers
001, 002
14 Dec 2030 · NDA 202324 · AXITINIB
US 8,791,140, substance patent
patent.txt lines 3,055, 3,064
Flags
substance
Product numbers
001, 002
17 Dec 2030 · NDA 022192 · ILOPERIDONE
US 9,074,255, use patent
patent.txt lines 1,154, 1,168, 1,182, 1,196, 1,210, 1,224, 1,238
Flags
use code U-1674
Product numbers
001, 002, 003, 004, 005, 006, 007
17 Dec 2030 · NDA 210493 · FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE
US 10,828,297, use patent
patent.txt lines 11,482, 11,494
Flags
use code U-2301
Product numbers
001, 002
22 Dec 2030 · NDA 021829 · ROTIGOTINE
US 10,130,589, product patent
patent.txt lines 708, 713, 718, 723, 728, 733
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
22 Dec 2030 · NDA 021829 · ROTIGOTINE
US 10,350,174, product patent
patent.txt lines 709, 714, 719, 724, 729, 734
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
23 Dec 2030 · NDA 209531 · NUSINERSEN SODIUM
US 8,361,977, substance and product patent
patent.txt lines 10,618, 10,626, 10,633
Flags
substance product
Product numbers
001, 002, 003
28 Dec 2030 · NDA 213189 · TIRBANIBULIN
US 7,300,931, substance and product patent
patent.txt line 14,725
Flags
substance product
Product numbers
001
29 Dec 2030 · NDA 208051 · NERATINIB MALEATE
US 7,399,865, substance and product patent
patent.txt line 8,017
Flags
substance product
Product numbers
001
31 Dec 2030 · NDA 021964 · METHYLNALTREXONE BROMIDE
US 8,247,425, use patent
patent.txt lines 833, 840, 847
Flags
use code U-1185
Product numbers
001, 002, 003

Pediatric exclusivity, as listed (74)

16 Jan 2030 · NDA 204370 · CARIPRAZINE HYDROCHLORIDE
US RE47350 with pediatric exclusivity, as listed
patent.txt lines 4,558, 4,629, 4,646
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 005, 006
16 Jan 2030 · NDA 204370 · CARIPRAZINE HYDROCHLORIDE
US RE49110 with pediatric exclusivity, as listed
patent.txt lines 4,564, 4,582, 4,598, 4,613, 4,634, 4,651
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005, 006
16 Jan 2030 · NDA 204370 · CARIPRAZINE HYDROCHLORIDE
US RE49302 with pediatric exclusivity, as listed
patent.txt lines 4,569, 4,587, 4,602, 4,617
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
5 Feb 2030 · NDA 201280 · LINAGLIPTIN
US 10,034,877 with pediatric exclusivity, as listed
patent.txt line 2,326
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
5 Feb 2030 · NDA 201280 · LINAGLIPTIN
US 9,486,526 with pediatric exclusivity, as listed
patent.txt line 2,342
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
12 Feb 2030 · NDA 207947 · SELEXIPAG
US 9,173,881 with pediatric exclusivity, as listed
patent.txt lines 7,702, 7,714, 7,726, 7,738, 7,750, 7,762, 7,774, 7,786, 7,798, 7,810
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005, 006, 007, 008, 010, 011
12 Feb 2030 · NDA 214275 · SELEXIPAG
US 9,173,881 with pediatric exclusivity, as listed
patent.txt line 15,662
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Feb 2030 · NDA 203188 · IVACAFTOR
US 10,646,481 with pediatric exclusivity, as listed
patent.txt line 3,651
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Feb 2030 · NDA 203188 · IVACAFTOR
US 11,564,916 with pediatric exclusivity, as listed
patent.txt line 3,653
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Feb 2030 · NDA 203188 · IVACAFTOR
US 12,458,635 with pediatric exclusivity, as listed
patent.txt line 3,655
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
13 Feb 2030 · NDA 207925 · IVACAFTOR
US 10,646,481 with pediatric exclusivity, as listed
patent.txt lines 7,493, 7,526, 7,559, 7,592, 7,620
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
13 Feb 2030 · NDA 207925 · IVACAFTOR
US 11,564,916 with pediatric exclusivity, as listed
patent.txt lines 7,497, 7,530, 7,563, 7,596, 7,624
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
13 Feb 2030 · NDA 207925 · IVACAFTOR
US 12,458,635 with pediatric exclusivity, as listed
patent.txt lines 7,503, 7,536, 7,569, 7,602, 7,630
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
20 Feb 2030 · NDA 209092 · RIBOCICLIB SUCCINATE
US 9,416,136 with pediatric exclusivity, as listed
patent.txt line 9,712
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
20 Feb 2030 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 9,416,136 with pediatric exclusivity, as listed
patent.txt line 11,053
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Mar 2030 · NDA 203094 · COBICISTAT
US 8,148,374 with pediatric exclusivity, as listed
patent.txt lines 3,623, 3,627
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Mar 2030 · NDA 203100 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US 8,148,374 with pediatric exclusivity, as listed
patent.txt line 3,635
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Mar 2030 · NDA 203100 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US 9,891,239 with pediatric exclusivity, as listed
patent.txt line 3,641
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Mar 2030 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,148,374 with pediatric exclusivity, as listed
patent.txt line 7,352
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
3 Mar 2030 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 9,891,239 with pediatric exclusivity, as listed
patent.txt line 7,362
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
6 Mar 2030 · NDA 214787 · REMDESIVIR
US 8,008,264 with pediatric exclusivity, as listed
patent.txt lines 16,150, 16,182
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
17 Mar 2030 · NDA 204370 · CARIPRAZINE HYDROCHLORIDE
US 7,737,142 with pediatric exclusivity, as listed
patent.txt lines 4,550, 4,574, 4,592, 4,607, 4,622, 4,639
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005, 006
23 Mar 2030 · NDA 022249 · BENDAMUSTINE HYDROCHLORIDE
US 8,344,006 with pediatric exclusivity, as listed
patent.txt lines 1,395, 1,401
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
003, 004
28 Mar 2030 · NDA 202611 · MIRABEGRON
US 10,842,780 with pediatric exclusivity, as listed
patent.txt lines 3,110, 3,123
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
28 Mar 2030 · NDA 202611 · MIRABEGRON
US 11,707,451 with pediatric exclusivity, as listed
patent.txt lines 3,113, 3,126
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
28 Mar 2030 · NDA 202611 · MIRABEGRON
US 12,059,409 with pediatric exclusivity, as listed
patent.txt lines 3,116, 3,129
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
28 Mar 2030 · NDA 202611 · MIRABEGRON
US 12,097,189 with pediatric exclusivity, as listed
patent.txt lines 3,118, 3,131
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
10 Apr 2030 · NDA 201292 · AFATINIB DIMALEATE
US 8,426,586 with pediatric exclusivity, as listed
patent.txt lines 2,400, 2,410, 2,420
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
14 Apr 2030 · NDA 204629 · EMPAGLIFLOZIN
US 8,551,957 with pediatric exclusivity, as listed
patent.txt lines 4,903, 4,934
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
14 Apr 2030 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 8,551,957 with pediatric exclusivity, as listed
patent.txt lines 6,197, 6,229
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
14 Apr 2030 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 8,551,957 with pediatric exclusivity, as listed
patent.txt lines 14,247, 14,277, 14,307, 14,336
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
21 Apr 2030 · NDA 202714 · CARFILZOMIB
US RE47954 with pediatric exclusivity, as listed
patent.txt lines 3,144, 3,154, 3,164
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
8 Jun 2030 · NDA 204790 · DOLUTEGRAVIR SODIUM
US 9,242,986 with pediatric exclusivity, as listed
patent.txt lines 5,005, 5,009, 5,013
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
8 Jun 2030 · NDA 205551 · ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
US 9,242,986 with pediatric exclusivity, as listed
patent.txt line 5,465
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
8 Jun 2030 · NDA 210192 · DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE
US 9,242,986 with pediatric exclusivity, as listed
patent.txt line 11,208
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
8 Jun 2030 · NDA 211994 · DOLUTEGRAVIR SODIUM; LAMIVUDINE
US 9,242,986 with pediatric exclusivity, as listed
patent.txt line 13,378
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
8 Jun 2030 · NDA 213983 · DOLUTEGRAVIR SODIUM
US 9,242,986 with pediatric exclusivity, as listed
patent.txt line 15,420
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
8 Jun 2030 · NDA 215413 · ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
US 9,242,986 with pediatric exclusivity, as listed
patent.txt line 16,887
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
9 Jun 2030 · NDA 209092 · RIBOCICLIB SUCCINATE
US 8,962,630 with pediatric exclusivity, as listed
patent.txt line 9,702
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
9 Jun 2030 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 8,962,630 with pediatric exclusivity, as listed
patent.txt line 11,047
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
16 Jun 2030 · NDA 202293 · DAPAGLIFLOZIN
US 7,919,598 with pediatric exclusivity, as listed
patent.txt lines 2,982, 3,020
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
16 Jun 2030 · NDA 205649 · DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 7,919,598 with pediatric exclusivity, as listed
patent.txt lines 5,712, 5,722, 5,732, 5,742, 5,752
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
16 Jun 2030 · NDA 209091 · DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE
US 7,919,598 with pediatric exclusivity, as listed
patent.txt lines 9,659, 9,675
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
19 Jun 2030 · NDA 201292 · AFATINIB DIMALEATE
US 8,545,884 with pediatric exclusivity, as listed
patent.txt lines 2,402, 2,412, 2,422
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
18 Jul 2030 · NDA 202293 · DAPAGLIFLOZIN
US 8,721,615 with pediatric exclusivity, as listed
patent.txt lines 2,999, 3,037
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
20 Jul 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 7,994,185 with pediatric exclusivity, as listed
patent.txt lines 3,252, 3,276
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
20 Jul 2030 · NDA 202806 · DABRAFENIB MESYLATE
US 8,415,345 with pediatric exclusivity, as listed
patent.txt lines 3,257, 3,281
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
20 Jul 2030 · NDA 207695 · CRISABOROLE
US 8,168,614 with pediatric exclusivity, as listed
patent.txt line 7,407
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
11 Aug 2030 · NDA 204629 · EMPAGLIFLOZIN
US 12,115,179 with pediatric exclusivity, as listed
patent.txt lines 4,887, 4,918
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
11 Aug 2030 · NDA 206073 · EMPAGLIFLOZIN; LINAGLIPTIN
US 12,115,179 with pediatric exclusivity, as listed
patent.txt lines 6,182, 6,214
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
11 Aug 2030 · NDA 206111 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,115,179 with pediatric exclusivity, as listed
patent.txt lines 6,302, 6,333, 6,362, 6,391
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
11 Aug 2030 · NDA 208658 · EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 12,115,179 with pediatric exclusivity, as listed
patent.txt lines 9,049, 9,081, 9,111, 9,141
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
11 Aug 2030 · NDA 212614 · EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 12,115,179 with pediatric exclusivity, as listed
patent.txt lines 14,237, 14,267, 14,297, 14,326
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
8 Sep 2030 · NDA 204275 · FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US 8,534,281 with pediatric exclusivity, as listed
patent.txt lines 4,433, 4,443, 4,451
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
8 Sep 2030 · NDA 209482 · FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US 8,534,281 with pediatric exclusivity, as listed
patent.txt lines 10,408, 10,415
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
15 Sep 2030 · NDA 208694 · CETIRIZINE HYDROCHLORIDE
US 8,829,005 with pediatric exclusivity, as listed
patent.txt line 9,237
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
17 Sep 2030 · NDA 022287 · DEXLANSOPRAZOLE
US 8,173,158 with pediatric exclusivity, as listed
patent.txt lines 1,555, 1,569
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
17 Oct 2030 · NDA 022433 · TICAGRELOR
US 8,425,934 with pediatric exclusivity, as listed
patent.txt lines 1,900, 1,905
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
29 Oct 2030 · NDA 207318 · PIMAVANSERIN TARTRATE
US 7,601,740 with pediatric exclusivity, as listed
patent.txt lines 7,232, 7,241
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
29 Oct 2030 · NDA 210793 · PIMAVANSERIN TARTRATE
US 7,601,740 with pediatric exclusivity, as listed
patent.txt line 12,146
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
30 Oct 2030 · NDA 203100 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
US 8,633,219 with pediatric exclusivity, as listed
patent.txt line 3,637
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
30 Oct 2030 · NDA 207561 · COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US 8,633,219 with pediatric exclusivity, as listed
patent.txt line 7,354
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001
19 Nov 2030 · NDA 204026 · POMALIDOMIDE
US 10,555,939 with pediatric exclusivity, as listed
patent.txt lines 4,196, 4,202, 4,208, 4,214
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
19 Nov 2030 · NDA 204026 · POMALIDOMIDE
US 9,993,467 with pediatric exclusivity, as listed
patent.txt lines 4,200, 4,206, 4,212, 4,218
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
21 Nov 2030 · NDA 201281 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,155,705 with pediatric exclusivity, as listed
patent.txt lines 2,358, 2,376, 2,394
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
21 Nov 2030 · NDA 208026 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 9,155,705 with pediatric exclusivity, as listed
patent.txt lines 7,982, 8,001
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
25 Nov 2030 · NDA 209092 · RIBOCICLIB SUCCINATE
US 8,685,980 with pediatric exclusivity, as listed
patent.txt line 9,700
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
25 Nov 2030 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
US 8,685,980 with pediatric exclusivity, as listed
patent.txt line 11,045
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001
26 Nov 2030 · NDA 202293 · DAPAGLIFLOZIN
US 8,685,934 with pediatric exclusivity, as listed
patent.txt lines 2,995, 3,033
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
26 Nov 2030 · NDA 205649 · DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US 8,685,934 with pediatric exclusivity, as listed
patent.txt lines 5,716, 5,726, 5,736, 5,746, 5,756
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005
4 Dec 2030 · NDA 201280 · LINAGLIPTIN
US 8,846,695 with pediatric exclusivity, as listed
patent.txt line 2,336
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001
4 Dec 2030 · NDA 201281 · LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US 8,846,695 with pediatric exclusivity, as listed
patent.txt lines 2,354, 2,372, 2,390
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003
25 Dec 2030 · NDA 207947 · SELEXIPAG
US 9,284,280 with pediatric exclusivity, as listed
patent.txt lines 7,704, 7,716, 7,728, 7,740, 7,752, 7,764, 7,776, 7,788, 7,800, 7,812
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004, 005, 006, 007, 008, 010, 011
25 Dec 2030 · NDA 214275 · SELEXIPAG
US 9,284,280 with pediatric exclusivity, as listed
patent.txt line 15,664
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001

Non-patent exclusivity (29)

1 Jan 2030 · NDA 209092 · RIBOCICLIB SUCCINATE
PED exclusivity
exclusivity.txt line 762
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001
1 Jan 2030 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE
PED exclusivity
exclusivity.txt line 816
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001
19 Jan 2030 · NDA 213217 · ZANUBRUTINIB
ODE-274 exclusivity
exclusivity.txt line 1,163
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
19 Jan 2030 · NDA 218785 · ZANUBRUTINIB
ODE* exclusivity
exclusivity.txt line 2,198
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
24 Feb 2030 · NDA 205552 · IBRUTINIB
PED exclusivity
exclusivity.txt lines 505, 509
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002
24 Feb 2030 · NDA 210563 · IBRUTINIB
PED exclusivity
exclusivity.txt lines 892, 896, 900, 904
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003, 004
25 Feb 2030 · NDA 213983 · DOLUTEGRAVIR SODIUM
PED exclusivity
exclusivity.txt line 1,287
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001
13 Mar 2030 · NDA 214662 · MARALIXIBAT CHLORIDE
ODE-429 exclusivity
exclusivity.txt line 1,351
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
13 Mar 2030 · NDA 214662 · MARALIXIBAT CHLORIDE
ODE* exclusivity
exclusivity.txt line 1,354
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
002
16 Mar 2030 · NDA 202806 · DABRAFENIB MESYLATE
ODE-428 exclusivity
exclusivity.txt lines 287, 291
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
16 Mar 2030 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
ODE-428 exclusivity
exclusivity.txt lines 369, 373, 377
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
21 Mar 2030 · NDA 213246 · SELPERCATINIB
PED exclusivity
exclusivity.txt lines 1,180–1,181, 1,202–1,203
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002
1 May 2030 · NDA 214755 · SODIUM OXYBATE
ODE-431 exclusivity
exclusivity.txt lines 1,371, 1,374, 1,377, 1,380
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003, 004
3 May 2030 · NDA 207925 · IVACAFTOR
ODE-435 exclusivity
exclusivity.txt lines 646, 652
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
004, 005
5 Jun 2030 · NDA 209939 · LETERMOVIR
ODE-423 exclusivity
exclusivity.txt lines 821, 827
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
5 Jun 2030 · NDA 209940 · LETERMOVIR
ODE-423 exclusivity
exclusivity.txt lines 833, 839
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
18 Aug 2030 · NDA 209241 · VALBENAZINE TOSYLATE
ODE-440 exclusivity
exclusivity.txt lines 768, 770, 772
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
16 Sep 2030 · NDA 202806 · DABRAFENIB MESYLATE
PED exclusivity
exclusivity.txt lines 289, 293
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002
16 Sep 2030 · NDA 204114 · TRAMETINIB DIMETHYL SULFOXIDE
PED exclusivity
exclusivity.txt lines 371, 375, 379
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
26 Sep 2030 · NDA 203341 · BOSUTINIB MONOHYDRATE
ODE-444 exclusivity
exclusivity.txt lines 308, 312, 316
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
11 Oct 2030 · NDA 210496 · ENCORAFENIB
ODE-445 exclusivity
exclusivity.txt lines 883, 887
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
20 Oct 2030 · NDA 214938 · VOSORITIDE
ODE-449 exclusivity
exclusivity.txt lines 1,427, 1,431, 1,435
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002, 003
24 Oct 2030 · NDA 211192 · IVOSIDENIB
ODE-447 exclusivity
exclusivity.txt line 945
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
3 Nov 2030 · NDA 207925 · IVACAFTOR
PED exclusivity
exclusivity.txt lines 649, 655
Definition
Pediatric exclusivity (to be checked against FDA's list)
Product numbers
004, 005
8 Dec 2030 · NDA 207500 · ISAVUCONAZONIUM SULFATE
ODE-454 exclusivity
exclusivity.txt lines 594, 605
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
8 Dec 2030 · NDA 207500 · ISAVUCONAZONIUM SULFATE
ODE-458 exclusivity
exclusivity.txt lines 595, 606
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001, 002
8 Dec 2030 · NDA 207501 · ISAVUCONAZONIUM SULFATE
ODE-453 exclusivity
exclusivity.txt line 615
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
8 Dec 2030 · NDA 207501 · ISAVUCONAZONIUM SULFATE
ODE-459 exclusivity
exclusivity.txt line 616
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001
20 Dec 2030 · NDA 215935 · BUDESONIDE
ODE-464 exclusivity
exclusivity.txt line 1,676
Definition
Orphan drug exclusivity (to be checked against FDA's list)
Product numbers
001